Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2023-03-17 00:00:00 ET · period of report 2023-03-16 · accession 0001415889-23-005120 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-17 | 2023-03-16 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $214.39 | -6,000 | 38.3K | -14% | -$1.29M |
| D | 2023-03-17 | 2023-03-16 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $120.26 | +6,000 | 42.6K | +16% | +$721.6K |
| D | 2023-03-17 | 2023-03-16 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -6,000 | 44.5K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-16 | S | D | 1,526 | $215.40 | 36,799 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $215.02 to $215.695. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2023-03-16 | S | D | 200 | $216.09 | 36,599 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $216.06 to $216.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2023-03-16 | M | A | 6,000 | $120.26 | 42,599 | D | — | — | (F2) Includes 112 shares acquired on March 3, 2023, under the United Therapeutics Corporation Employee Stock Purchase Plan. |
| 4 | Common | Common Stock | 2023-03-16 | S | D | 475 | $211.87 | 42,124 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $211.80 to $212.255. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2023-03-16 | S | D | 1,277 | $213.61 | 40,847 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $212.98 to $213.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2023-03-16 | S | D | 2,522 | $214.52 | 38,325 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $214.00 to $214.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Derivative | Stock Options | 2023-03-16 | M | D | 6,000 | $0.00 | 44,500 | D | $120.26 · 2017-03-15 to 2026-03-15 | 6,000 Common Stock |